A novel approach for treatment of unresectable pancreatic cancer: Design of radioactive stents and trial studies on normal pigs

Clinical Cancer Research

Volumn 13, Issue 11, 2007, Pages 3326-3332

  Liu, Yan ^a   Liu, Jun Lou ^a   Cai, Zhen Zhai ^a   Lu, Zheng ^a   Dong, Yuan Hang ^a   Li, Zhao Shen ^a   Gong, Yan Fang ^a   Man, Xiao Hua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BRACHYTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEBRIDEMENT; FEASIBILITY STUDY; FOLLOW UP; HISTOPATHOLOGY; NONHUMAN; PANCREAS CANCER; PANCREAS DUCT; PANCREATIC DUCT PERFORATION; PERFORATION; PRIORITY JOURNAL; RADIATION DOSE; SAFETY; STENT; SWINE;

ANIMALS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; HUMANS; IODINE RADIOISOTOPES; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PLASTICS; PROGNOSIS; RADIOMETRY; RESEARCH DESIGN; STENTS; SWINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34250680940     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0154     Document Type: Article

References (26)

1. Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician 2006;73:485-92.
2. Tanaka M. Important clues to the diagnosis of pancreatic cancer. Rocz Akad Med Bialymst 2005;50:69-72.
3. Vilaichone RK, Schulz HJ, Mahachai V. Endoscopic management of pancreatic cancer. J Med Assoc Thai 2005;88:S352-6.
4. Willett CG, Safran H, Abrams RA, Regine WF, Rich TA. Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys 2003;56:31-7.
5. Dobelbower RR, Montemaggi P. Brachytherapy for pancreatic cancer: a review. Hepatogastroenterology 1996;43:333-7.
6. Takacsi-Nagy Z, Varga J, Poller I, et al. Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy. Hepatogastroenterology 2002;49:844-6.
7. Aird EG, Folkard M, Mayes CR, Bownes PJ, Lawson JM, Joiner MC. A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro. Br J Radiol 2001;74:56-61.
8. Dondelinger RF, Ghysels MP, Brisbois D, et al. Relevant radiological anatomy of the pig as a training model in interventional radiology. Eur Radiol 1998;8:1254-73.
9. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 1995;22:209-34.
10. Wuu CS, Ennis RD, Schiff PB, Lee EK, Zaider M. Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants. Int J Radiat Oncol Biol Phys 2000;47:815-20.
11. 125I brachytherapy seed with characteristic X rays from its constitutive materials. Med Phys 2002;29:1397-420.
12. Mutignani M, Shah SK, Morganti AG, Perri V, Macchia G, Costamagna G. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung. Endoscopy 2002;34:555-9.
13. Montemaggi P, Morganti AG, Dobelbower RR, Jr., et al. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation? Radiology 1996;199:861-6.
14. Dvorak J, Petera J, Papik Z, et al. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region. Hepatogastroenterology 2002;49:1045-7.
15. Zopf T, Riemann JF. Therapy of pancreatic and bile duct tumors: value of radiotherapy and photodynamic therapy. Schweiz Rundsch Med Prax 2000;89:1293-8.
16. Bodner WR, Hilaris BS, Mastoras DA. Radiation therapy in pancreatic cancer: current practice and future trends. J Clin Gastroenterol 2000;30:230-3.
17. Sakurai H, Mitsuhashi N, Harashima K, et al. CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinoma. Brachytherapy 2004;3:222-30.
18. Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys 2004;60:1385-92.
19. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E. Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mL. Am J Clin Oncol 2004;27:611-5.
20. Viola A, Major T, Julow J. The importance of postoperative CT image fusion verification of stereotactic interstitial irradiation for brain tumors. Int J Radiat Oncol Biol Phys 2004;60:322-8.
21. Chan HH, Nishioka NS, Mino M, et al. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc 2004;59:95-9.
22. Won JH, Lee JD, Wang HJ, et al. Self-expandable covered metallic esophageal stent impregnated with beta-emitting radionuclide: an experimental study in canine esophagus. Int J Radiat Oncol Biol Phys 2002;53:1005-13.
23. Won JH, Lee JD, Wang HJ, et al. Effects of a holmium-166 incorporated covered stent placement in normal canine common bile ducts. J Vasc Interv Radiol 2005;16:705-11.
24. Nori D, Merimsky O, Osian AD, Heffernan M, Cortes E, Turner JW. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: aphase I-IIstudy. J Surg Oncol 1996;61:300-5.
25. Smits ME, Groen AK, Mok KS, van Marle J, Tytgat GN, Huibregtse K. Analysis of occluded pancreatic stents and juices in patients with chronic pancreatitis. Gastrointest Endosc 1997;45:52-8.
26. Kozarek R, Hovde O, Attia F, France R. Do pancreatic duct stents cause or prevent pancreatic sepsis? Gastrointest Endosc 2003;58:505-9.